Sign up for the QMED & MD+DI Daily newsletter.
Let’s Talk Medtech spoke with Dave Hadley, Phd, Senior VP of Research & Development of Cardiac Insight, about the company and the exploding ECG market.
May 26, 2021
1 Min Read
spaxiax - stock.adobe.com
Cardiac Insight is seeing a major uptick in ECG screenings. The Seattle, WA-based company reported there was more than a 70% surge in sales of the Cardea 20/20 ECG in 1Q21.
Let’s Talk Medtech recently spoke with Dave Hadley, Phd, Senior VP of Research & Development. He is the inventor of Cardea 20/20, about the surge and recent interest in the ECG market. Dr. Hadley has more than 30 years of hands-on experience blending customer needs with information technology through research and development.
Cardiac Insight was named a finalist for this year’s Medical Design Excellence Awards.
Click here to access the most recent episode of Let's Talk Medtech.
About the Author(s)
You May Also Like
BioSig Cuts a Substantial Number of PositionsFeb 20, 2024|2 Min Read
Philips BrightView Imaging System Hit with Class I RecallFeb 20, 2024|2 Min Read
Medtronic Exits Ventilator Market, Raises FY24 OutlookFeb 20, 2024|4 Min Read
Medical Device Suppliers Unite to Form the WCDAFeb 20, 2024